Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship in Pediatric Neuropsychiatry, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1993 - 1994
  • Fellowship in Child and Adolescent Psychiatry, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1991 - 1993
  • General Psychiatry Residency, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1988 - 1992
  • M.D., University of Rochester School of Medicine and Denistry 1988
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Anagnostou, E, Jones, N, Huerta, M, Halladay, AK, Wang, P, Scahill, L, Horrigan, JP, Kasari, C, Lord, C, Choi, D, Sullivan, K, and Dawson, G. "Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder." Autism : the International Journal of Research and Practice 19, no. 5 (July 2015): 622-636. (Review)  Full Text
    • Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia research 164, no. 1-3 (May 2015): 136-142.  Full Text
    • Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H<inf>3</inf> receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia Research 164, no. 1-3 (January 1, 2015): 136-142.  Full Text
    • Scahill, L, Aman, MG, Lecavalier, L, Halladay, AK, Bishop, SL, Bodfish, JW, Grondhuis, S, Jones, N, Horrigan, JP, Cook, EH, Handen, BL, King, BH, Pearson, DA, McCracken, JT, Sullivan, KA, and Dawson, G. "Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder." Autism : the International Journal of Research and Practice 19, no. 1 (January 2015): 38-52. (Review)  Full Text
    • Lecavalier, L, Wood, JJ, Halladay, AK, Jones, NE, Aman, MG, Cook, EH, Handen, BL, King, BH, Pearson, DA, Hallett, V, Sullivan, KA, Grondhuis, S, Bishop, SL, Horrigan, JP, Dawson, G, and Scahill, L. "Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder." Journal of Autism and Developmental Disorders 44, no. 5 (May 2014): 1128-1143. (Review)  Full Text

  • Conference Papers

    • Jarskog, FF, Grove, RA, McEvoy, JP, Keefe, RSE, Lowy, MT, Horrigan, JP, and Peykamian, MA. "Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy." April 15, 2012.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.